Coronavirus therapeutics. Volume I, Basic science and therapy development / Alexzander A.A. Asea, Punit Kaur, editors.
Asea, Alexzander A. A.; Kaur, Punit.
2021
RC114.5
Available Online

Linked e-resources

Linked Resource Online Access
Concurrent users Unlimited
Authorized users Authorized users
Document Delivery Supplied Can lend chapters, not whole ebooks

Details

Title Coronavirus therapeutics. Volume I, Basic science and therapy development / Alexzander A.A. Asea, Punit Kaur, editors.
ISBN 3030851095
9783030851095 (electronic bk.)
3030851087
9783030851088
DOI https://doi.org/10.1007/978-3-030-85109-5
Publication Details Cham : Springer, 2021.
Language English
Description 1 online resource (225 pages)
Item Number 10.1007/978-3-030-85109-5 doi
Call Number RC114.5
Dewey Decimal Classification 616.9/1
Summary The book Coronavirus Therapeutics Volume I provides the most comprehensive review on contemporary knowledge on the origin, structural biology and molecular aspects of Coronaviruses. It also describes the etiology and pathogeny and therapeutic targets including vaccine drug candidates against Coronaviruses in the light of current scientific knowledge. Using an integrative approach to the understanding of Coronaviruses structure, function and immunobiology, the contributors provide a synopsis of novel mechanisms by which Coronaviruses can be treated. Key basic and clinical research laboratories from major universities, academic medical hospitals, biotechnology and pharmaceutical laboratories around the world have contributed articles that review present research activity on the role of heat shock proteins in human diseases and importantly project the field into the future. The book is a must read for graduate students. medical students, basic science researchers and postdoctoral scholars in the fields of Cancer Biology, Oncology, Cardiovascular Diseases, Microbiology, Inflammation, Translational Medicine, Clinical Research, Biotechnology, Cell & Molecular Medicine, Pharmaceutical Scientists and Researchers involved in Drug Discovery.
Access Note Access limited to authorized users.
Source of Description Description based on print version record.
Added Author Asea, Alexzander A. A.
Kaur, Punit.
Series Advances in experimental medicine and biology ; v. 1352.
Available in Other Form Coronavirus Therapeutics - Volume I.
Linked Resources Online Access
Record Appears in Online Resources > Ebooks
All Resources
Origin and structural biology of Novel Coronavirus (SARS-CoV-2)
The Molecular Virology of Coronaviruses with Special Reference to SARS-CoV-2
Epidemiology, transmission and molecular immunopathology of SARS-CoV-2
Epidemiology and Etiopathogeny of Covid-19
Immunological and Hematological Response in COVID-19
Toll-like receptors (TLRs) as Therapeutic Targets for Treating SARS-CoV-2: An Immunobiological Perspective
Potential drug strategies to target Coronaviruses
Possible therapeutic intervention strategies for COVID-19 by manipulating the cellular proteostasis network
The potential impact of statins in the treatment of patients with COVID-19 infection
Anticoronavirus activity of water-soluble pristine C60 fullerenes: in vitro and in silico screening
Application of Nanoscale materials and nanotechnology against viral infection: A special focus on Coronaviruses
Obesity: A Risk Factor for Covid-19
Cytokine Storm and Failed Resolution in COVID-19: Taking Cue from Multiple Sclerosis.

Browse Subjects

Show more subjects...

Statistics

from
to
Export